Desensitisation to allopurinol.
作者信息
Kelsey S M, Struthers G R, Beswick T, Blake D R
出版信息
Ann Rheum Dis. 1987 Jan;46(1):84. doi: 10.1136/ard.46.1.84.
Abstract
摘要
相似文献
1
Desensitisation to allopurinol.别嘌醇脱敏
Ann Rheum Dis. 1987 Jan;46(1):84. doi: 10.1136/ard.46.1.84.
2
How to prevent allopurinol hypersensitivity reactions?如何预防别嘌醇过敏反应？
Rheumatology (Oxford). 2018 Jan 1;57(suppl_1):i35-i41. doi: 10.1093/rheumatology/kex422.
3
Allopurinol hypersensitivity: investigating the cause and minimizing the risk.别嘌醇超敏反应：探究病因并降低风险。
Nat Rev Rheumatol. 2016 Apr;12(4):235-42. doi: 10.1038/nrrheum.2015.132. Epub 2015 Sep 29.
4
A critical reappraisal of allopurinol dosing, safety, and efficacy for hyperuricemia in gout.对痛风高尿酸血症中别嘌醇剂量、安全性及疗效的批判性重新评估。
Curr Rheumatol Rep. 2009 Apr;11(2):135-40. doi: 10.1007/s11926-009-0019-z.
5
An effective strategy to prevent allopurinol-induced hypersensitivity by HLA typing.通过 HLA 分型预防别嘌醇诱导的过敏反应的有效策略。
Genet Med. 2015 Oct;17(10):807-14. doi: 10.1038/gim.2014.195. Epub 2015 Jan 29.
6
[Prevention of adverse reactions to allopurinol].[别嘌醇不良反应的预防]
An Med Interna. 1989 Jan;6(1):48.
7
Successful desensitization of a fixed drug eruption caused by allopurinol.成功使由别嘌醇引起的固定性药疹脱敏。
J Allergy Clin Immunol. 1998 Feb;101(2 Pt 1):286-7. doi: 10.1016/S0091-6749(98)70396-3.
8
Allopurinol sensitivity in a patient with chronic tophaceous gout: success of intravenous desensitization after failure of oral desensitization.
Arthritis Rheum. 1991 Oct;34(10):1329-31. doi: 10.1002/art.1780341020.
9
An unusual case of allopurinol hypersensitivity syndrome potentiated by intravitreal bevacizumab.一例由玻璃体内注射贝伐单抗诱发的别嘌醇超敏综合征罕见病例。
Eur J Clin Pharmacol. 2011 May;67(5):537-8. doi: 10.1007/s00228-010-0945-8. Epub 2010 Nov 11.
10
Desensitisation to allopurinol.别嘌醇脱敏
Ann Rheum Dis. 1987 Nov;46(11):875. doi: 10.1136/ard.46.11.875-a.
引用本文的文献
1
Difficult gout and new approaches for control of hyperuricemia in the allopurinol-allergic patient.难治性痛风及别嘌醇过敏患者高尿酸血症控制的新方法。
Curr Rheumatol Rep. 2001 Feb;3(1):29-35. doi: 10.1007/s11926-001-0048-8.
2
Sulphasalazine desensitisation in patients with arthritis.
Ir J Med Sci. 1994 May;163(5):238-9. doi: 10.1007/BF02943259.
3
Alternatives to allopurinol.别嘌醇的替代药物。
Ann Rheum Dis. 1987 Jun;46(6):493. doi: 10.1136/ard.46.6.493-a.
4
Desensitisation to allopurinol.别嘌醇脱敏
Ann Rheum Dis. 1987 Nov;46(11):875. doi: 10.1136/ard.46.11.875-a.
本文引用的文献
1
Reinstitution of allopurinol therapy for gouty arthritis after cutaneous reactions.皮肤反应后重新使用别嘌醇治疗痛风性关节炎。
Can Med Assoc J. 1980 Jul 19;123(2):128-9.
2
Allopurinol hypersensitivity in a patient with severe, chronic, tophaceous gout.
Arthritis Rheum. 1985 Jun;28(6):707-9. doi: 10.1002/art.1780280617.
3
Sulphasalazine in rheumatoid arthritis: desensitising the patient with a skin rash.柳氮磺胺吡啶治疗类风湿性关节炎：使皮疹患者脱敏。
Ann Rheum Dis. 1986 Feb;45(2):139-40. doi: 10.1136/ard.45.2.139.
4
Desensitisation in a patient with chronic renal disease and severe allergy to allopurinol.一名患有慢性肾病且对别嘌醇严重过敏患者的脱敏治疗
Br Med J. 1976 Aug 21;2(6033):458. doi: 10.1136/bmj.2.6033.458.
Zotero 插件